Author Nehlmeier, Inga

1 to 20 of 48 Items
  • 2024 | Journal Article
    ​ ​Immune responses following BNT162b2 XBB.1.5 vaccination in patients on haemodialysis in Germany​
    Cossmann, A.; Hoffmann, M.; Stankov, M. V; Lürken, K.; Morillas Ramos, G.; Kempf, A. & Nehlmeier, I. et al.​ (2024) 
    The Lancet Infectious Diseases,.​ DOI: https://doi.org/10.1016/S1473-3099(23)00783-1 
    ​Details  DOI 
  • 2024 | Journal Article
    ​ ​SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency​
    Zhang, L.; Kempf, A.; Nehlmeier, I.; Cossmann, A.; Richter, A.; Bdeir, N. & Graichen, L. et al.​ (2024) 
    Cell, 187(3) pp. 596​-608.e17​.​ DOI: https://doi.org/10.1016/j.cell.2023.12.025 
    ​Details  DOI 
  • 2024 | Journal Article
    ​ ​Cytoskeletal β-tubulin and cysteine cathepsin L deregulation by SARS-CoV-2 spike protein interaction with the neuronal model cell line SH-SY5Y​
    Oliveira, B. R.; Nehlmeier, I.; Kempf, A. M.; Venugopalan, V.; Rehders, M.; Ceniza, M. E. & Cavalcanti, P. A. T. et al.​ (2024) 
    Biochimie,.​ DOI: https://doi.org/10.1016/j.biochi.2024.02.006 
    ​Details  DOI 
  • 2023 | Journal Article | 
    ​ ​Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage​
    Nehlmeier, I.; Kempf, A.; Arora, P.; Cossmann, A.; Dopfer-Jablonka, A.; Stankov, M. V. & Schulz, S. R. et al.​ (2023) 
    Cellular & Molecular Immunology, pp. 1​-3​.​ DOI: https://doi.org/10.1038/s41423-023-01030-z 
    ​Details  DOI  PMID  PMC 
  • 2023 | Journal Article | 
    ​ ​Profound neutralization evasion and augmented host cell entry are hallmarks of the fast-spreading SARS-CoV-2 lineage XBB.1.5​
    Hoffmann, M.; Arora, P.; Nehlmeier, I.; Kempf, A.; Cossmann, A.; Schulz, S. R. & Morillas Ramos, G. et al.​ (2023) 
    Cellular & Molecular Immunology, 20(4) pp. 419​-422​.​ DOI: https://doi.org/10.1038/s41423-023-00988-0 
    ​Details  DOI  PMID  PMC 
  • 2023 | Journal Article | 
    ​ ​TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection​
    Metzdorf, K.; Jacobsen, H.; Greweling-Pils, M. C.; Hoffmann, M.; Lüddecke, T.; Miller, F. & Melcher, L. et al.​ (2023) 
    Viruses, 15(2).​ DOI: https://doi.org/10.3390/v15020271 
    ​Details  DOI 
  • 2023 | Journal Article
    ​ ​Polyvalent Nano-Lectin Potently Neutralizes SARS-CoV-2 by Targeting Glycans on the Viral Spike Protein​
    Budhadev, D.; Hooper, J.; Rocha, C.; Nehlmeier, I.; Kempf, A. M.; Hoffmann, M. & Krüger, N. et al.​ (2023) 
    JACS Au, 3(6) pp. 1755​-1766​.​ DOI: https://doi.org/10.1021/jacsau.3c00163 
    ​Details  DOI 
  • 2023 | Journal Article
    ​ ​Effect of hybrid immunity and bivalent booster vaccination on omicron sublineage neutralisation​
    Hoffmann, M.; Behrens, G. M N; Arora, P.; Kempf, A.; Nehlmeier, I.; Cossmann, A. & Manthey, L. et al.​ (2023) 
    The Lancet Infectious Diseases, 23(1) pp. 25​-28​.​ DOI: https://doi.org/10.1016/S1473-3099(22)00792-7 
    ​Details  DOI 
  • 2023 | Journal Article | 
    ​ ​Omicron subvariant BA.5 efficiently infects lung cells​
    Hoffmann, M.; Wong, L. Wong, Lok-Yin Roy; Arora, P.; Zhang, L.; Rocha, C.; Odle, A. & Nehlmeier, I. et al.​ (2023) 
    Nature Communications, 14(1).​ DOI: https://doi.org/10.1038/s41467-023-39147-4 
    ​Details  DOI 
  • 2023 | Journal Article
    ​ ​Neutralisation sensitivity of SARS-CoV-2 lineages EG.5.1 and XBB.2.3​
    Zhang, L.; Kempf, A.; Nehlmeier, I.; Cossmann, A.; Dopfer-Jablonka, A.; Stankov, M. V & Schulz, S. R et al.​ (2023) 
    The Lancet Infectious Diseases, 23(10) pp. e391​-e392​.​ DOI: https://doi.org/10.1016/S1473-3099(23)00547-9 
    ​Details  DOI 
  • 2022 | Journal Article | 
    ​ ​The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant​
    Arora, P.; Zhang, L.; Rocha, C.; Graichen, L.; Nehlmeier, I.; Kempf, A. & Cossmann, A. et al.​ (2022) 
    International Journal of Molecular Sciences, 23(22) pp. 14057​.​ DOI: https://doi.org/10.3390/ijms232214057 
    ​Details  DOI 
  • 2022 | Journal Article | 
    ​ ​Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1​
    Sidarovich, A.; Krüger, N.; Rocha, C.; Graichen, L.; Kempf, A.; Nehlmeier, I. & Lier, M. et al.​ (2022) 
    Viruses, 14(11) art. 2475​.​ DOI: https://doi.org/10.3390/v14112475 
    ​Details  DOI  PMID  PMC 
  • 2022 | Journal Article
    ​ ​Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy​
    Hoffmann, M.; Sidarovich, A.; Arora, P.; Krüger, N.; Nehlmeier, I.; Kempf, A. & Graichen, L. et al.​ (2022) 
    mBio,.​ DOI: https://doi.org/10.1128/mbio.00364-22 
    ​Details  DOI 
  • 2022 | Journal Article
    ​ ​SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination​
    Arora, P.; Kempf, A.; Nehlmeier, I.; Graichen, L.; Winkler, M. S.; Lier, M. & Schulz, S. et al.​ (2022) 
    Cell Reports, art. S2211124722005186​.​ DOI: https://doi.org/10.1016/j.celrep.2022.110754 
    ​Details  DOI 
  • 2022 | Journal Article
    ​ ​Augmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5​
    Arora, P.; Kempf, A.; Nehlmeier, I.; Schulz, S. R; Cossmann, A.; Stankov, M. V & Jäck, H.-M. et al.​ (2022) 
    The Lancet Infectious Diseases, 22(8) pp. 1117​-1118​.​ DOI: https://doi.org/10.1016/S1473-3099(22)00422-4 
    ​Details  DOI 
  • 2022 | Journal Article
    ​ ​Omicron sublineage BQ.1.1 resistance to monoclonal antibodies​
    Arora, P.; Kempf, A.; Nehlmeier, I.; Schulz, S. R; Jäck, H.-M.; Pöhlmann, S. & Hoffmann, M.​ (2022) 
    The Lancet Infectious Diseases,.​ DOI: https://doi.org/10.1016/S1473-3099(22)00733-2 
    ​Details  DOI 
  • 2022 | Journal Article
    ​ ​The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic​
    Hoffmann, M.; Krüger, N.; Schulz, S.; Cossmann, A.; Rocha, C.; Kempf, A. & Nehlmeier, I. et al.​ (2022) 
    Cell, 185(3) pp. 447​-456.e11​.​ DOI: https://doi.org/10.1016/j.cell.2021.12.032 
    ​Details  DOI 
  • 2022 | Journal Article
    ​ ​Lung cell entry, cell–cell fusion capacity, and neutralisation sensitivity of omicron sublineage BA.2.75​
    Arora, P.; Nehlmeier, I.; Kempf, A.; Cossmann, A.; Schulz, S. R; Dopfer-Jablonka, A. & Baier, E. et al.​ (2022) 
    The Lancet Infectious Diseases,.​ DOI: https://doi.org/10.1016/S1473-3099(22)00591-6 
    ​Details  DOI 
  • 2022 | Journal Article | 
    ​ ​No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2​
    Arora, P.; Kempf, A.; Nehlmeier, I.; Graichen, L.; Winkler, M. S.; Lier, M. & Schulz, S. et al.​ (2022) 
    Cellular & Molecular Immunology,.​ DOI: https://doi.org/10.1038/s41423-021-00811-8 
    ​Details  DOI 
  • 2022 | Journal Article | 
    ​ ​Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2​
    Arora, P.; Kempf, A.; Nehlmeier, I.; Graichen, L.; Schulz, S.; Cossmann, A. & Dopfer-Jablonka, A. et al.​ (2022) 
    Cellular & Molecular Immunology,.​ DOI: https://doi.org/10.1038/s41423-022-00870-5 
    ​Details  DOI 

Researcher

Göttingen All

Sort

issue date

ASC DESC

Items per Page

10 20 50 100